Legal Opinion
Cephalon, Inc. v. Watson Pharmaceuticals, Inc.
Court of Appeals for the Federal Circuit
Decided February 14, 2013No. 2011-1325PublishedCited by 53 opinions
1Opinion of the Court
WALLACH, Circuit Judge.
This action arises out of the filing of an Abbreviated New Drug Application (“ANDA”) by Watson Pharmaceuticals, Inc., Watson Laboratories, Inc., and Watson Pharma, Inc. (collectively, “Watson”) for a generic version of FENTORA®. In response to Watson’s ANDA filing, Ce-phalon, Inc. and CIMA Labs, Inc. (collectively, “Cephalon”) instituted this patent infringement suit at the United States District Court for the District of Delaware asserting U.S. Patent Nos. 6,200,604 (“the '604 patent”) and 6,974,590 (“the '590 pat ent”). After a bench trial, the district court found…
2Cases cited23 opinions
- Herbert Markman and Positek, Inc. v. Westview Instruments, Inc. And Althon Enterprises, Inc.Court of Appeals for the Federal Circuit · 1995
- Warner-Jenkinson Co. v. Hilton Davis Chemical Co.Supreme Court of the United States · 1997
- MacHine Co. v. MurphySupreme Court of the United States · 1878
- In Re Jack R. Wands, Vincent R. Zurawski, Jr., and Hubert J.P. SchoemakerCourt of Appeals for the Federal Circuit · 1988
- Texas Instruments Incorporated v. Cypress Semiconductor Corporation, Lsi Logic Corporation, and Vlsi Technology, Inc.Court of Appeals for the Federal Circuit · 1996
18 more not listed; retrieve them via the Exa API.
3Cited by53 opinions
- Alcon Research, Ltd. v. Barr Laboratories, Inc.Court of Appeals for the Federal Circuit · 2014
- Wyeth & Cordis Corp. v. Abbott LaboratoriesCourt of Appeals for the Federal Circuit · 2013
- McRo, Inc. v. Bandai Namco Games AmericaCourt of Appeals for the Federal Circuit · 2020
- Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc.Court of Appeals for the Federal Circuit · 2013
- Convolve, Inc. v. Compaq Computer Corp.Court of Appeals for the Federal Circuit · 2013
48 more not listed; retrieve them via the Exa API.